A highly skilled team dedicated to develop drugs for neurological disorders
Yann GODFRIN, Ph.D.
Chief Executive Officer
20+ years of experience in management of Biopharmaceutical companies focused product development from bench to Phase III clinical trial. Dr Godfrin was co-Founder, former CEO and CSO of ERYTECH Pharma (EPA/NASDAQ: ERYP) and former CEO of Hemoxymed Europe. In addition to his entrepreurship, Dr Godfrin is an expert in pre-clinical and clinical product development strategy and has been consultant for several biopharmaceutical companies. He is the inventor of more than 15 patents families and several scientific publications. Dr Godfrin holds a Ph.D. degree in Health & Life Sciences (University of Nantes, France), an Engineer degree in Biomedical Sciences (University of Compiègne, France) and a Master degree in Pharmaceutical Drug Development (University of Lyon, France).
Manuel BLANC, Ph.D.
Chief Scientific Officer
15+ years of experience in R&D, Strategy & Business Development in the biotech – pharma – healthcare industry. Prior to joining Axoltis Pharma in November 2017 Dr BLANC served as Business Development & Licensing Project Leader for Erytech Pharma, directing projects to support corporate strategy, clinical and preclinical R&D and Intellectual Property. Prior to joining Erytech Pharma, Dr. BLANC served as Corporate Strategic Intelligence Manager for SANOFI, in the Strategy Department, supporting Business Development and R&D. With dual-skills in Science & Business, Dr. BLANC holds a PhD in Life Sciences (University of Keele, U.K.), an MSc in Biochemistry and Structural Biology (University of Grenoble, France) and an MBA in Biotechnology & Pharmaceutical Management (France).
Clinical Operations Director
15+ years of experience in clinical trial management. Prior to joining Axoltis Pharma, he served as Clinical Project Manager for a mid-size CRO, managing various full-service national and international projects with biotech and big/mid-size pharma companies, from regulatory submissions to clinical study report writing. He recently participated in the development of drugs in rare diseases, managing several partners in E.U. and in the USA. M. MARIE holds a Master Degree in Biology (University of Bourgogne, France), a Degree Specialized in Clinical Research (University of Caen, France) and certified in International Project Management (AFITEP, Paris).